NCT00691262View on ClinicalTrials.gov

Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Dermatitis, Atopic
Interventions
DRUG

tacrolimus ointment

transdermal

Trial Locations (9)

16100

Genova

23900

Lecco

35128

Padua

40100

Bologna

80138

Napoli

95124

Catania

00161

Roma

00165

Roma

00167

Roma

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY